Publication | Closed Access

Non-adrenoceptor [3H]idazoxan binding sites (I2-imidazoline sites) are increased in postmortem brain from patients with Alzheimer's disease

I2-imidazoline SitesAlzheimer's DiseasePostmortem BrainMedicineDementiaNeuropharmacologyNeurochemical BiomarkersNeuroprotectionNeurologyNeuroscienceBrain PathologyCerebral Blood FlowNeuropathologyPharmacologyNeuroinflammation